Adjuvant Carboplatin and Paclitaxel Chemotherapy Followed by Radiotherapy in High-Risk Endometrial Cancer: A Retrospective Analysis
Purpose: The best adjuvant treatment in high-risk endometrial cancer remains unclear. Although adjuvant chemotherapy seems to improve overall survival (OS) in locally advanced disease, the role of adding radiotherapy is not certain. We evaluated the outcomes of patients with high-risk endometrial ca...
Հիմնական հեղինակներ: | Renata Rodrigues da Cunha Colombo Bonadio, Renata Gondim Meira Velame Azevedo, Guilherme Harada, Samantha Cabral Severino da Costa, Vanessa Costa Miranda, Daniela de Freitas, Elias Abdo Filho, Patricia Alves de Oliveira Ferreira, Flavia Gabrielli, Maria Del Pilar Estevez Diz |
---|---|
Ձևաչափ: | Հոդված |
Լեզու: | English |
Հրապարակվել է: |
American Society of Clinical Oncology
2018-01-01
|
Շարք: | Journal of Global Oncology |
Առցանց հասանելիություն: | http://ascopubs.org/doi/10.1200/JGO.17.00146 |
Նմանատիպ նյութեր
-
A Prospective Study of Adjuvant Radiotherapy Concomitant with Cisplatin Followed by Paclitaxel-Carboplatin in High Risk Early Stage Endometrial Cancer
: Tarek Kamel, և այլն
Հրապարակվել է: (2016-12-01) -
Carboplatin plus Paclitaxel in the First Line Therapy of Recurrent and Advances Endometrial Cancer
: Hamid Attarian, և այլն
Հրապարակվել է: (2009-07-01) -
Carboplatin plus Paclitaxel in the First Line Therapy of Recurrent and Advances Endometrial Cancer
: Hamid Attarian, և այլն
Հրապարակվել է: (2009-09-01) -
Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC
: Katsurada N, և այլն
Հրապարակվել է: (2020-02-01) -
Perspectives on PARP Inhibitor Combinations for Ovarian Cancer
: Renata Colombo Bonadio, և այլն
Հրապարակվել է: (2021-12-01)